TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PHAT

Phathom Pharmaceuticals Inc

Healthcare · Biotechnology

7.50$ -3.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Phathom Pharmaceuticals Inc (PHAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 327 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PHAT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
237 414 356 319 387 378 294 250 240 259 305 327
227 397 340 305 374 360 265 219 208 229 277 296
214 381 322 276 335 297 212 150 135 130 181 182
214 381 322 276 335 297 212 150 135 130 181 182
1.6 3.9 11 21 39 36 51 56 78 81 97
0.1 1.2 1.5 2.2 3.1 3.2 3.2 3.4 3.6 5.5 6.5 7.7
255 487 505 553 574 632 633 656 663 697 642 671
24 39 43 47 65 86 74 92 93 132 125 154
0.7 0.7 0.7 0.7 0.7 0.5 0.3 0.2 0.6 0.6 0.7 0.7
5.8 13 8.4 7.7 7.1 11 12 4.0 1.1 5.0 6.4 5.4
99 138 149 174 176 201 203 205 207 209 164 165
-18 -73 -149 -234 -187 -254 -338 -406 -423 -438 -337 -344
-849 -929 -1,012 -1,103 -1,189 -1,263 -1,357 -1,433 -1,463 -1,484 -1,515 -1,532
57 51 58 59 65 71 72 72 73 74 82 84

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?